Insiders · SBFM

SBFM insider transactions

Sunshine Biopharma Inc. (SBFM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

SBFM insiders

Everyone who has filed a Form 4 or 5 at Sunshine Biopharma Inc., latest first. Follow anyone to get their next filing.

• David NatanDirector
• Steve N. SlilatyChief Executive Officer, Director, 10% owner+$12K
• Camille SebaalyOfficer+$53.4K

Recent Form 3, 4, and 5 filings for SBFM

• 86d
  Director Natan David was granted 58,300 shares, increasing direct ownership by 583% to 68,300 units (SEC Form 4)

  4 - Sunshine Biopharma Inc. (0001402328) (Issuer)
• 205d
  SEC Form 4 filed by Natan David

  4 - Sunshine Biopharma Inc. (0001402328) (Issuer)
• 654d
  New insider Roy Michel claimed ownership of 1 shares (SEC Form 3)

  3 - Sunshine Biopharma Inc. (0001402328) (Issuer)
• 975d
  Slilaty Steve N. bought $10,000 worth of Series B Preferred Stock (100,000 units at $0.10), increasing direct ownership by 333% to 130,000 units (SEC Form 4)

  4 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 997d
  Slilaty Steve N. bought $2,000 worth of Series B Preferred Stock (20,000 units at $0.10), increasing direct ownership by 200% to 30,000 units (SEC Form 4)

  4 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1001d
  SEC Form 3 filed by new insider Beaudoin Marc

  3 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1435d
  SEC Form 4: Sebaaly Camille bought $22,905 worth of shares (30,000 units at $0.76), increasing direct ownership by 21% to 174,465 units

  4 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1471d
  SEC Form 3: New insider Chamoun Malek claimed ownership of 3,700,000 shares

  3 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1614d
  SEC Form 4: Sebaaly Camille bought $30,500 worth of shares (25,000 units at $1.22), increasing direct ownership by 21% to 144,465 units

  4 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1717d
  SEC Form 4: Slilaty Steve N. returned $99,000 worth of Series B Preferred Stock to the company (990,000 units at $0.10), decreasing direct ownership by 99% to 10,000 units

  4 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1721d
  SEC Form 3: New insider Natan David claimed no ownership of stock in the company

  3 - Sunshine Biopharma, Inc (0001402328) (Issuer)
• 1721d
  SEC Form 3: New insider Keller Andrew Mark claimed no ownership of stock in the company

  3 - Sunshine Biopharma, Inc (0001402328) (Issuer)